Abstract

Despite the lack of randomized trials comparing transapical aortic valve implantation (TA-AVI) with surgical aortic valve replacement, there is consensus that the approach may be advantageous for a high-risk group of patients.1,2 Nevertheless, several complications are associated with TA-AVI. Paravalvular leak resulting in aortic insufficiency of grade II or more is reported at a high incidence3 and promotes left ventricular dysfunction, hemolysis, and endocarditis.4 The onset of atrioventricular block (AVB) is correlated with the implantation of large-diameter valves in patients with a small annulus diameter.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.